The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7563445 B1

PDF
Full Text
Expired
Date of Patent:
Jul. 21, 2009

Filed:

Aug. 26, 2002
Applicants:

Cornelis J. M. Melief, Haarlem, NL;

Stephen P. Schoenberger, Encinitas, CA (US);

Rienk Offringa, Leiden, NL;

Rene Toes, Leiden, NL;

Inventors:

Cornelis J. M. Melief, Haarlem, NL;

Stephen P. Schoenberger, Encinitas, CA (US);

Rienk Offringa, Leiden, NL;

Rene Toes, Leiden, NL;

Assignee:

Keygene N.V., Wageningen, NL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/12 (2006.01); A61K 38/08 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed is a method and composition for treating tumors or infectious diseases, wherein the composition includes CD40 binding molecules together with CTL-activating peptides, e.g., tumor antigens. Such composition is useful for enhancing the anti-tumor effect of a peptide tumor vaccine, or for otherwise activating CTLs so that the activated CTLs can act against tumorous or infected cells. The CD40 binding molecules can include antibody molecules, as well as homologues, analogues and modified or derived forms thereof, including immunoglobulin fragments like Fab, (Fab')and Fv, as well as other molecules including peptides, oligonucleotides, peptidomimetics and organic compounds which bind to CD40 and activate the CTL response.


Find Patent Forward Citations

Loading…